Jwa Hoon Kim

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Changhoon Yoo, Jwa Hoon Kim, Min‐Hee Ryu et al. · Liver Cancer · 2021 · 119 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or <i>POLE</i>-Mutated Metastatic or Unresectable Colorectal Cancer

Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek et al. · Cancer Research and Treatment · 2020 · 59 citations · Full text

Medicine, Immunology, Oncology +15

Predictive biomarkers for the efficacy of nivolumab as ≥ 3rd-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial

Jwa Hoon Kim, Min‐Hee Ryu, Young Soo Park et al. · BMC Cancer · 2022 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study

Seongman Bae, Ye‐Jee Kim, Min-Ju Kim et al. · Journal for ImmunoTherapy of Cancer · 2021 · 38 citations · Full text

Medicine, Immunology, Oncology +17